Reduction in prices of DNA sequencing is the factor basically augmenting the genotyping assays market. Genotyping assays determine differences in genetic make-up (genotype) of an individual by examination of his/her DNA sequence and compare it with the other individual’s sequence/reference sequence.
Continuous technological advancements are keeping the constructive disruption quotient (CDQ) on for genomic testing industry. The companies operating in the genotyping assays market are widening the applications of next generation sequencing to detect multiple Hepatitis C virus genotypes.
They are also widely using DNA biosensor/biochip for multiplex blood group genotyping in the under-developed economies in order to have preventive/curative health practices in place.
Genotyping is referred to as the technology capable of detecting small genetic differences that could result in major alterations in phenotypes, including physical differences that render uniqueness to the living beings and pathological alterations underlying the disease.
Genotyping by sequencing (GBS) offers an alternative to genome sequencing in entirety as it means reduction of complexity of genome. This is capable of generating big quantities of high-quality genetic markers.
Test results can make provisions for informed decisions to patients about management of health.
Some of the existing methods of genotyping include random amplified polymorphic detection (RAPD) of genomic DNA, restriction fragment length polymorphism identification (RFLPI) of genomic DNA, amplified fragment length polymorphism detection (AFLPD), hybridization to DNA microarrays or beads, polymerase chain reaction (PCR), DNA sequencing, and allele specific oligonucleotide (ASO) probes.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The price of sequencing has decreased on a significant note over the period of time owing to fierce competition amongst the key players coupled with adoption of advancing technology.
Sequencing a single genome cost US$ 100 Mn in the year 2001. This cost has drastically come down since the introduction of next generation sequencing, irrespective of technology or platform type.
Illumina had launched HiSeqX Ten in the year 2014. At that time, the cost was US$ 1000. After 8 years, i.e. in 2022, it launched NovaSeqX series, which aimed on reducing the cost to merely US$ 200.
The company is on the verge of launching an advanced version that could sequence close to 20,000 genomes per year, in comparison with 2022’s model sequencing 7,500 genomes.
Lowered costs with higher efficiency helps clinicians in incorporating genetic testing into the routine patient care, thereby enabling customized treatment plans and precise diagnoses. This shift has the capacity of significantly improving the patients’ quality of life, especially for those who have been battling rare genetic disorders.
Need to encompass maximum patients with reduced costs of DNA sequencing is thus accelerating the genotyping assays market.
Technological advancements such as PTC Tempo Thermal Cyclers are being designed with a user-friendly interface, along with versatile connectivity tools in order to simplify protocol management. The features encompass ability of monitoring and controlling cyclers using a dedicated cloud platform.
The thermal cyclers have been designed for consistently providing exceptional thermal performance. They provide scientists with the ability of easily adjusting and expanding their experiments in the laboratory.
The thermal cyclers also feature two exclusive dual blocks with manual lids, thereby facilitating concurrent execution of the two independent protocols. The thermal cyclers are customized to handle large samples. They have motorized tops that allow for smooth interfacing with robotics.
Technological advancements as mentioned above on continuous basis are thus expanding the genotyping assays industry size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest genotyping assays market insights, North America led genomic assays landscape in 2023 and the status quo is expected to remain unchanged during the forecast period. This is attributed to the U.S. housing a large number of biopharmaceutical & pharmaceutical companies, proactive government policies, and improvements in healthcare infrastructure.
Asia Pacific’s significant genotyping assays market growth in the near future is ascribed to increase in the number of clinical trials being conducted in countries such as India, China, Korea, Japan, Australia. Additionally, the pharma and biopharma sectors are incorporating the technological advancements at a rapid pace.
The key players in the genotyping assays market are launching new products to establish a robust foothold in the DNA Analysis landscape. For instance, in September 2023, Bio-Rad Laboratories, Inc. introduced PTC Tempo 384 and PTC Tempo 48/48 Thermal Cycler for cloning, sequencing, and genotyping. Such novel products offer superlative thermal performance and improved usability.
Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent, Danaher Corporation, Roche, GE HealthCare, Standard BioTools Inc., PerkinElmer, Eurofins Scientific SE, Bio-Rad Laboratories, Pacific Biosciences of California, Inc., GENEWIZ, Inc., and Integrated DNA Technologies, Inc.
are some of the key players covered in the genotyping assays market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 30.5 Bn |
| Market Forecast (Value) in 2034 | US$ 285.3 Bn |
| Growth Rate (CAGR) | 22.5% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 30.5 Bn in 2023
It is projected to grow at a CAGR of 22.5% from 2024 to 2034
Lowered prices of DNA sequencing and adoption of technological advancements
Diagnostics & research laboratories segment accounted for the largest share in 2023
North America was the dominant region in 2023
Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent, Danaher Corporation, Roche, GE HealthCare, Standard BioTools Inc., PerkinElmer, Eurofins Scientific SE, Bio-Rad Laboratories, Pacific Biosciences of California, Inc., GENEWIZ, Inc., and Integrated DNA Technologies, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Genotyping Assays Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Genotyping Assays Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Genotyping Assays Market Analysis and Forecast, by Product & Service
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product & Service, 2020-2034
6.3.1. Reagents & Kits
6.3.2. Genotyping Services
6.3.3. Instruments
6.3.3.1. Sequences & Amplifiers
6.3.3.2. Analyzers
6.3.4. Bioinformatics
6.3.4.1. Software
6.3.4.2. Services
6.4. Market Attractiveness, by Product & Service
7. Global Genotyping Assays Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. PCR
7.3.1.1. Real-time PCR
7.3.1.2. Digital PCR
7.3.2. Microarrays
7.3.3. Sequencing
7.3.3.1. NGS
7.3.3.2. Pyrosequencing
7.3.3.3. Sanger Sequencing
7.3.4. Capillary Electrophoresis
7.3.4.1. Amplified Fragment Length Polymorphism
7.3.4.2. Restricted Fragment Length Polymorphism
7.3.4.3. Single-Stranded Conformation Polymorphism
7.3.5. MALDI-TOF
7.3.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
7.4. Market Attractiveness, by Technology
8. Global Genotyping Assays Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Pharmacogenomics
8.3.2. Diagnostic & Personalized Medicine
8.3.3. Agricultural Biotechnology
8.3.4. Animal Genetics
8.3.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
8.4. Market Attractiveness, by Application
9. Global Genotyping Assays Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Pharmaceutical & Biopharmaceutical Companies
9.3.2. Diagnostic & Research Laboratories
9.3.3. Academic Institutes
9.3.4. Others (Animal and Aquagenetics Companies, etc.)
9.4. Market Attractiveness, by End-user
10. Global Genotyping Assays Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Genotyping Assays Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product & Service, 2020-2034
11.2.1. Reagents & Kits
11.2.2. Genotyping Services
11.2.3. Instruments
11.2.3.1. Sequences & Amplifiers
11.2.3.2. Analyzers
11.2.4. Bioinformatics
11.2.4.1. Software
11.2.4.2. Services
11.3. Market Attractiveness, by Product & Service
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. PCR
11.4.1.1. Real-time PCR
11.4.1.2. Digital PCR
11.4.2. Microarrays
11.4.3. Sequencing
11.4.3.1. NGS
11.4.3.2. Pyrosequencing
11.4.3.3. Sanger Sequencing
11.4.4. Capillary Electrophoresis
11.4.4.1. Amplified Fragment Length Polymorphism
11.4.4.2. Restricted Fragment Length Polymorphism
11.4.4.3. Single-Stranded Conformation Polymorphism
11.4.5. MALDI-TOF
11.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Pharmacogenomics
11.6.2. Diagnostic & Personalized Medicine
11.6.3. Agricultural Biotechnology
11.6.4. Animal Genetics
11.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Pharmaceutical & Biopharmaceutical Companies
11.8.2. Diagnostic & Research Laboratories
11.8.3. Academic Institutes
11.8.4. Others (Animal and Aquagenetics Companies, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product & Service
11.11.2. By Technology
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Genotyping Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product & Service, 2020-2034
12.2.1. Reagents & Kits
12.2.2. Genotyping Services
12.2.3. Instruments
12.2.3.1. Sequences & Amplifiers
12.2.3.2. Analyzers
12.2.4. Bioinformatics
12.2.4.1. Software
12.2.4.2. Services
12.3. Market Attractiveness, by Product & Service
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. PCR
12.4.1.1. Real-time PCR
12.4.1.2. Digital PCR
12.4.2. Microarrays
12.4.3. Sequencing
12.4.3.1. NGS
12.4.3.2. Pyrosequencing
12.4.3.3. Sanger Sequencing
12.4.4. Capillary Electrophoresis
12.4.4.1. Amplified Fragment Length Polymorphism
12.4.4.2. Restricted Fragment Length Polymorphism
12.4.4.3. Single-Stranded Conformation Polymorphism
12.4.5. MALDI-TOF
12.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Pharmacogenomics
12.6.2. Diagnostic & Personalized Medicine
12.6.3. Agricultural Biotechnology
12.6.4. Animal Genetics
12.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Pharmaceutical & Biopharmaceutical Companies
12.8.2. Diagnostic & Research Laboratories
12.8.3. Academic Institutes
12.8.4. Others (Animal and Aquagenetics Companies, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product & Service
12.11.2. By Technology
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Genotyping Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product & Service, 2020-2034
13.2.1. Reagents & Kits
13.2.2. Genotyping Services
13.2.3. Instruments
13.2.3.1. Sequences & Amplifiers
13.2.3.2. Analyzers
13.2.4. Bioinformatics
13.2.4.1. Software
13.2.4.2. Services
13.3. Market Attractiveness, by Product & Service
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. PCR
13.4.1.1. Real-time PCR
13.4.1.2. Digital PCR
13.4.2. Microarrays
13.4.3. Sequencing
13.4.3.1. NGS
13.4.3.2. Pyrosequencing
13.4.3.3. Sanger Sequencing
13.4.4. Capillary Electrophoresis
13.4.4.1. Amplified Fragment Length Polymorphism
13.4.4.2. Restricted Fragment Length Polymorphism
13.4.4.3. Single-Stranded Conformation Polymorphism
13.4.5. MALDI-TOF
13.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Pharmacogenomics
13.6.2. Diagnostic & Personalized Medicine
13.6.3. Agricultural Biotechnology
13.6.4. Animal Genetics
13.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Pharmaceutical & Biopharmaceutical Companies
13.8.2. Diagnostic & Research Laboratories
13.8.3. Academic Institutes
13.8.4. Others (Animal and Aquagenetics Companies, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product & Service
13.11.2. By Technology
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Genotyping Assays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product & Service, 2020-2034
14.2.1. Reagents & Kits
14.2.2. Genotyping Services
14.2.3. Instruments
14.2.3.1. Sequences & Amplifiers
14.2.3.2. Analyzers
14.2.4. Bioinformatics
14.2.4.1. Software
14.2.4.2. Services
14.3. Market Attractiveness, by Product & Service
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. PCR
14.4.1.1. Real-time PCR
14.4.1.2. Digital PCR
14.4.2. Microarrays
14.4.3. Sequencing
14.4.3.1. NGS
14.4.3.2. Pyrosequencing
14.4.3.3. Sanger Sequencing
14.4.4. Capillary Electrophoresis
14.4.4.1. Amplified Fragment Length Polymorphism
14.4.4.2. Restricted Fragment Length Polymorphism
14.4.4.3. Single-Stranded Conformation Polymorphism
14.4.5. MALDI-TOF
14.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Pharmacogenomics
14.6.2. Diagnostic & Personalized Medicine
14.6.3. Agricultural Biotechnology
14.6.4. Animal Genetics
14.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Pharmaceutical & Biopharmaceutical Companies
14.8.2. Diagnostic & Research Laboratories
14.8.3. Academic Institutes
14.8.4. Others (Animal and Aquagenetics Companies, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product & Service
14.11.2. By Technology
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Genotyping Assays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product & Service, 2020-2034
15.2.1. Reagents & Kits
15.2.2. Genotyping Services
15.2.3. Instruments
15.2.3.1. Sequences & Amplifiers
15.2.3.2. Analyzers
15.2.4. Bioinformatics
15.2.4.1. Software
15.2.4.2. Services
15.3. Market Attractiveness, by Product & Service
15.4. Market Value Forecast, by Technology, 2020-2034
15.4.1. PCR
15.4.1.1. Real-time PCR
15.4.1.2. Digital PCR
15.4.2. Microarrays
15.4.3. Sequencing
15.4.3.1. NGS
15.4.3.2. Pyrosequencing
15.4.3.3. Sanger Sequencing
15.4.4. Capillary Electrophoresis
15.4.4.1. Amplified Fragment Length Polymorphism
15.4.4.2. Restricted Fragment Length Polymorphism
15.4.4.3. Single-Stranded Conformation Polymorphism
15.4.5. MALDI-TOF
15.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Pharmacogenomics
15.6.2. Diagnostic & Personalized Medicine
15.6.3. Agricultural Biotechnology
15.6.4. Animal Genetics
15.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Pharmaceutical & Biopharmaceutical Companies
15.8.2. Diagnostic & Research Laboratories
15.8.3. Academic Institutes
15.8.4. Others (Animal and Aquagenetics Companies, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product & Service
15.11.2. By Technology
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Illumina, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN N.V.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Agilent
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Danaher Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Roche
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. GE HealthCare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Standard BioTools Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. PerkinElmer
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Eurofins Scientific SE
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Bio-Rad Laboratories
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Pacific Biosciences of California, Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. GENEWIZ, Inc.
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Integrated DNA Technologies, Inc.
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
List of Tables
Table 01: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 02: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 03: Global Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 05: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 06: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 07: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 08: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 09: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 10: North America Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 11: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 13: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 14: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 15: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 18: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 19: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 20: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 23: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 24: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 25: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
Table 28: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 29: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 30: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Genotyping Assays Market Size (US$ Bn), by Region, 2023 and 2034
Figure 02: Global Genotyping Assays Market Revenue (US$ Bn), by Product & Service, 2023
Figure 03: Global Genotyping Assays Market Value Share, by Product & Service, 2023
Figure 04: Global Genotyping Assays Market Revenue (US$ Bn), by Technology, 2023
Figure 05: Global Genotyping Assays Market Value Share, by Technology, 2023
Figure 06: Global Genotyping Assays Market Revenue (US$ Bn), by Application, 2023
Figure 07: Global Genotyping Assays Market Value Share, by Application, 2023
Figure 08: Global Genotyping Assays Market Revenue (US$ Bn), by End-user, 2023
Figure 09: Global Genotyping Assays Market Value Share, by End-user, 2023
Figure 10: Global Genotyping Assays Market Value Share, by Region, 2023
Figure 11: Global Genotyping Assays Market Value (US$ Bn) Forecast, 2020-2034
Figure 12: Global Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 13: Global Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 14: Global Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 15: Global Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 16: Global Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 17: Global Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 18: Global Genotyping Assays Market Revenue (US$ Bn), by End-user, 2023
Figure 19: Global Genotyping Assays Market Value Share, by End-user, 2023
Figure 20: Global Genotyping Assays Market Value Share Analysis, by Region, 2023 and 2034
Figure 21: Global Genotyping Assays Market Attractiveness Analysis, by Region, 2024-2034
Figure 22: North America Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 23: North America Genotyping Assays Market Attractiveness Analysis, by Country, 2024-2034
Figure 24: North America Genotyping Assays Market Value Share Analysis, by Country, 2023 and 2034
Figure 25: North America Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 26: North America Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 27: North America Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 28: North America Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
Figure 29: North America Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 30: North America Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 31: North America Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 32: North America Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Europe Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 34: Europe Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 35: Europe Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 36: Europe Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 37: Europe Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 38: Europe Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 39: Europe Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Europe Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 41: Europe Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 42: Europe Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 43: Europe Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
Figure 44: Asia Pacific Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 45: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 46: Asia Pacific Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 47: Asia Pacific Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 48: Asia Pacific Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 49: Asia Pacific Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Asia Pacific Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 52: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 53: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 54: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by End-user, 2023-2034
Figure 55: Latin America Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 56: Latin America Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Latin America Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Latin America Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 59: Latin America Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 60: Latin America Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 61: Latin America Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Latin America Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 63: Latin America Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 64: Latin America Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 65: Latin America Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
Figure 66: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 67: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 69: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
Figure 70: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
Figure 71: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
Figure 72: Middle East & Africa Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
Figure 74: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
Figure 75: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
Figure 76: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Genotyping Assays Market
